Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2026-04-18 @ 5:20 PM
Study NCT ID:
NCT05281718
Status:
COMPLETED
Last Update Posted:
2025-01-20
First Post:
2022-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
Sponsor:
Tulane University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-11
First Submit QC Date:
None
Study First Post Date:
2022-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-17
Last Update Post Date:
2025-01-20
Last Update Post Date Type:
ACTUAL